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a  b  s  t  r  a  c  t
Coronary  artery  bypass  graft (CABG)  surgery  is an  established  treatment  for  complex  coronary  artery
disease.  There  is a widely  held  belief  that  cognitive  decline  presents  post-operatively.  A  consensus  state-
ment  of  core  neuropsychological  tests  was  published  in  1995  with  the  intention  of guiding  investigation
into  this  issue.  We  conducted  a meta-analysis  evaluating  the  evidence  for cognitive  decline post-CABG
surgery.  Twenty-eight  published  studies,  accumulating  data  from  up to 2043  patients  undergoing  CABG
surgery,  were  included.  Results  were examined  at ‘very  early’  (<2  weeks),  ‘early’ (3 months)  and  ‘late’ognition
eta-analysis
(6–12  months)  time  periods  post-operatively.  Two  of  the  four  tests  suggested  an  initial  very  early  decrease
in  psychomotor  speed  that  was  not  present  at subsequent  testing.  Rather,  the omnibus  data  indicated
subtle  improvement  in function  relative  to pre-operative  baseline  testing.  Our ﬁndings  suggest  improve-
ment  in cognitive  function  in the  ﬁrst  year  following  CABG  surgery.  This  is contrary  to  the more  negative
interpretation  of results  of  some  individual  publications  included  in  our  review,  which  may  reﬂect  poor
outcomes  in a few  patients  and/or  methodological  issues.© 2012 Elsevier Ltd.    
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. Introduction
The neurological consequences of CABG have been well docu-
ented (Newman et al., 2006; Selnes et al., 2012) but there remains
ncertainty about the severity and timing of post-operative cog-
itive decline, and its relationship with any underlying damage
o the brain. There is a continuum of decline from mild, tran-
ient cognitive impairment without evidence of brain insult, to the
ore devastating occurrence of clinical stroke and perhaps even
nset of dementia at the other extreme. A recently published study
escribed a total overall stroke incidence of 1.6% in 45,432 patients
resenting for CABG surgery between 1982 and 2010 (Tarakji et al.,
011). Estimates of the risk of milder impairments are much more
ariable, ranging from an early 3% estimate (Roach et al., 1996), to
onsiderably higher when clinically silent brain lesions are taken
nto account (e.g. 45% by magnetic resonance imaging (MRI) diffu-
ion weighted imaging) (Knipp et al., 2004).
The potential for post-operative cognitive decline has resulted
n the greatest uncertainty in this literature. Post-operative cogni-
ive decline has been described in approximately half of patients at
ime of discharge from hospital (Knipp et al., 2008; Newman et al.,
001; Norkiené et al., 2011; Slater et al., 2009), with subsequent
ecrease in incidence to around one-ﬁfth to one-third of patients
nly a few weeks later (Knipp et al., 2008; Newman et al., 2001;
an Dijk et al., 2002), and then a late rise in incidence at one to ﬁve
ears post-operatively (Knipp et al., 2004; Newman et al., 2006; Van
ijk et al., 2002, 2007). Other studies (McKhann et al., 2005; Selnes
t al., 2003; Van den Goor et al., 2008) have reported improvement
n cognition in the early period post-CABG, with some going so far
s to argue that “there are no detrimental effects of uncomplicated
ardiac surgery assisted by cardio-pulmonary bypass on cognitive
unction, irrespective of the type of cardiac surgery.” (Van den Goor
t al., 2008). Notwithstanding this divergence of opinion, an under-
tanding of the magnitude, time course and proﬁle of any cognitive
ecline following CABG surgery is necessary for risk assessment
nd possible implementation of neuroprotective strategies (Selnes
t al., 2012). The present study aims to add to a few but increasing
umber of well-controlled studies (Keizer et al., 2005; Selnes et al.,
009) and systematic reviews (Alston, 2011; Rudolph et al., 2010)
hat seek to address this issue.
The majority of studies have dichotomized cognitive outcome
fter surgery, classifying patients as “impaired” or “unimpaired”
n the basis of their baseline cognitive performance. Whilst this
pproach has the advantage of delivering a headline rate of cog-
itive impairment in the population of interest, it has several
imitations, not least of which is a lack of consensus for deﬁning
mpairment (Rudolph et al., 2010). One comparison of the different
riteria used in studies of post-operative cognitive function found
hat there were at least nine different statistical deﬁnitions of cog-
itive decline (Rasmussen et al., 2001). The authors applied these
ifferent deﬁnitions to a control sample of 176 non-hospitalized
lderly control participants and found that the estimates of cog-
itive decline differed dramatically depending on the criterion
sed, ranging from 0 to 39% of cases. Others have recommended
hat the quantiﬁcation of the decline observed in each patient is
rovided as a proportion of the change seen in a control group
ver a similar interval, thereby controlling for background levels
f change and for practice effects (Silbert et al., 2004); however,
his approach has not been widely adopted. The variable criteria
or ‘decline’ may  explain some of the discrepancy in prevalence
f post-operative cognitive decline and limits our ability to make
nferences across different studies in different centres. Further-
ore, the reduction of continuous variables into binary variables
imits the sensitivity to relative severity of impairment across indi-
iduals and domains, and over time. Consequently, analysis of
he raw (mean) scores and standard deviations of these studies isvioral Reviews 36 (2012) 2118–2129 2119
required for any meaningful conclusions to be made (Selnes et al.,
2012).
A further factor which complicates interpretation of the lit-
erature is the variability in timing of cognitive assessment. The
follow-up period used by different studies ranges from up to one
week after surgery (pre-discharge from hospital), to three or more
years at the other extreme (Newman et al., 2001; Selnes et al., 2009;
Van Dijk et al., 2008). As outlined above, the highest rates of post-
operative cognitive decline (approximately 50% of patients) have
been observed in the early weeks following surgery, followed by
a signiﬁcant reduction in incidence over the ﬁrst 6 months (Knipp
et al., 2008; Newman et al., 2001; Van Dijk et al., 2002). In addition
to the severity of the observed impairment, its likely duration and
persistence has clear clinical implications, but this has rarely been
systematically addressed in this population using case-controlled
longitudinal studies with similar criteria for determining decline.
There  is no reason to predict that all regions of the brain will
be uniformly affected during CABG surgery. For example, the rel-
ative vulnerability of the hippocampus to hypoperfusion (Román,
2004), such as may  be encountered during CABG surgery, and its
association with memory would lead cognitive neuroscientists to
predict that this domain of function will be particularly suscep-
tible to decline. However, other processes, such as the release
of micro-emboli during cardio-pulmonary bypass, may  affect the
brain differently, for example, focusing any insult on deep white
matter at arterial borderzones (Moody et al., 1990) and hence
reduce speed of psychomotor processing amongst other domains
of function. In part to reﬂect this heterogeneity of the possible
neural consequences of CABG surgery, a wide variety of pencil
and paper, and computerized (Van den Goor et al., 2008) cogni-
tive tests have been employed. Comparison across these different
tests is problematic, as they vary in their psychometric properties,
particularly their susceptibility to practice effects and their sensi-
tivity to subtle impairment and longitudinal change, as well as in
their speciﬁcity to the brain insults thought to be associated with
CABG (Lewis et al., 2004; Polunina, 2008; Rasmussen et al., 2001).
In an attempt to provide some coherence to the ﬁeld, Murkin and
colleagues came together in 1995 (Murkin et al., 1995) to draft a
consensus statement on the assessment of cognitive function after
cardiac surgery. This included a small battery of tests with par-
allel forms and established data on test-retest reliability which
they recommended formed the core assessment of cognition in
the CABG-surgery population. Since publication, a large number
of authors have at least partially adopted the recommendations of
the consensus statement enabling us now, approximately ﬁfteen
years later, to examine the proﬁle of cognitive outcome following
CABG surgery.
With  the above issues in mind, we performed a meta-analysis
to evaluate trends in neuropsychological results across studies
of patients undergoing CABG surgery. Results were examined
parametrically (from means and standard deviations) rather than
dichotomously (e.g. ‘impaired or not’). We  also considered the
effect of post-operative interval, and conducted a regression anal-
ysis to explore potential associations. By combining data from
studies that have used the same neuropsychological tests recom-
mended by the consensus statement, we hope to get a fuller picture
of the severity and duration of any cognitive dysfunction. This may
offer an important insight for wider efforts to understand and quan-
tify post-operative cognitive decline after CABG surgery.
2.  Methods2.1. Search strategy
Published studies assessing neuropsychological performance
after CABG were considered. Studies were identiﬁed from
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Table 1
Study  and patient characteristics for the included studies.
CPB N Age (SD) Male (%) Diabetes (%) HBP  (%) Stroke (%) Dropout (n) Follow up Neuropsychological tests
Ahlgren et al. (2003) On 23 65.7  3.3 91 17 39 0  4–6 wk RAVLT, Trails A, Trails B
Baker et al. (2001) On 14 65.9  8.3 71 30 70 0 4
1  wk, 6 mo Trails A, Trails BOff 12  61.7 11.7 92 11 56 0
Djaiani  et al. (2007) On 95 67.5 6 89 38 71 0 6 wks GPB
Dupuis  et al. (2006) On 364 – – 60.7 22.6 2.7 0 5–11 mo  Digit Symbol
Ernest  et al. (2006) On 61 63.7 10.7 81 31 79 3.6 15
2  mo,  6 mo Digit Symbol, GPB, RAVLT, Trains A, Trails B
Off 46 63.2  9 78 27 79 7.1
Grigore  et al. (2002) On 100 62.1  10.6 70 18 63 3 0  6 wks Digit Symbol, Trails B
Heyer et al. (2002) On 35 62.5 11.3 89 36.1 52.7 6 5 d, 6 wk GPB, Trails A, Trails B
Kadoi and Goto (2006) On 88 62.4  10.5 80 22 55.7  0 6 mo GPB, Trails A, Trails B
Khosravi et al. (2005) On 20 65.2 9.3 80 0 1 wk, 4–6 mo Digit Symbol, RAVLT
Knipp  et al. (2004) On 20 67.6  8.7 83 35 76 0 6 3  mo Trails A, Trails B
Lee  et al. (2003) On 30 66 11.2  73 37 87 3 1
2  wks, 1 yr Digit Symbol, GPB, RAVLT, Trains A, Trails B
Off 30  65.5 9.1 80 20 70 7
Lund  et al. (2005) On 52 65.2 8.4 72 43 6.6 8
3  mo,  1 yr Digit Symbol, RAVLT
Off 49  64.8 7.8 85 42 8.3 6
Müllges et al. (2002) On 52 63 7 84.6 31 68 0 0 9 d, 3–5 yrs Trails A, Trails B
Newman  et al. (2001) Off 261 61 10.4 71.6 13.2 51.8 4.8 < 2ks, 6 wks, 6 mo RAVLT, GPB
Rankin  et al. (2003) Both 43 61.1  9.8 77 9  2–3 mo  GPB, Trails A, Trails B
Robson et al. (2000) On 102 59 9 88.2 0 3 mo  Digit Symbol, GPB, RAVLT, Trails A, Trails B
Rubens  et al. (2007) On 125 58.7 9.3 90 32 70 12 1 wk, 3 mo GPB, RAVLT, Trails A, Trails B
Selnes et al. (2009) On 152 63.6  9.4 76 30 64 5  30
1  yr, 72 mo GPB, RAVLT, Trails A, Trails BOff  75 66 10.5 72 37 68 3
Silbert  et al. (2004) On 50 66.3 82 30 30 0 0 6 d Digit Symbol, GPB, Trails A, Trails B
Silbert  et al. (2008) On 281 68.4 7.8 75.5 24 81 3 mo,  12 mo Digit Symbol, GPB, Trails A, Trails B
Stroobant et al. (2008) Both 53 59 7.5 88.9 28.8 53.9 0–11 6 d, 6 mo, 3–5 yrs GPB, RAVLT, Trails B
Stygall et al. (2003) On 107 60.5 8.1 86.9 8 3–5 d GPB, RAVLT, Trails A, Trails B
Sugiyama et al. (2002) On 65 63 9 83  32 35 0 10–14 d Digit symbol
Szalma  et al. (2006) On 47 56.2 5.5 78 0 1 6 wks Digit Symbol
Van  Dijk et al. (2002) On 139 60.8 8.8 71 17 44 3 0–20
3  mo,  12 mo Digit Symbol, GPB, RAVLT, Trails B
Off 142 61.7  9.2 66 9 40 4  14
Vedin et al. (2006) On 37 65 9.1 84 19 46 0 0–37
1  wk, 1 mo, 6 mo Digit Symbol, Trails A, Trails BOff  33 65 9.1 78 18 52
Wang et al. (2002) On 45 59.3 9.4 97.8 20 53.3 0 0 1 wk Digit Symbol, GPB
Zamvar  et al. (2002) On 30 61.6 10 90 0 0–15
1  wk, 10 wk Digit Symbol, GPB, RAVLT, Trails A, Trails BOff  30 63.5 9.1 83
Zimpfer  et al. (2004) On 104 64.1 9.8 89.1 40.2 82.5 0 16 1 wk, 36 mo  Trails A
CPB – Cardiopulmonary bypass; HBP – High Blood Pressure; GPB - Grooved Pegboard Test.
iobehavioral Reviews 36 (2012) 2118–2129 2121
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ystematic literature searches of databases including Cochrane
reviews and registry of controlled trials), Medline and PsycINFO.
earches were limited to the past 10 years in order to provide a pic-
ure of outcome following current practice. This also allowed time
or the recommendations of the consensus statement, which was
ublished in 1995, to impact on the wider literature.
The search strategy included the terms ‘coronary revascu-
arisation’, ‘coronary artery bypass’, ‘neurocognitive’, ‘cognitive’,
neuropsych*’ and ‘brain function’. All studies were then reviewed
o determine if they had included neuropsychological outcomes as
n endpoint. A search of other reviews of CABG was  also conducted,
hecking the reference lists of these articles for further relevant
tudies.
.2. Inclusion and exclusion criteria
Trials and observational studies evaluating cognitive function
efore and after CABG surgery in the years 2000–2010 were
ncluded. Neuropsychological testing as a study endpoint was  a
rerequisite. Studies were selected for inclusion if they included
atients with ﬁrst time CABG as their only surgical intervention.
oth on and off pump CABG were included; whilst some earlier
tudies have suggested worse outcome when cardio-pulmonary
ypass is used (“on-pump”) (Stroobant et al., 2005), others have
hown that there is no signiﬁcant difference in outcome (Selnes
t al., 2009); this variable was nonetheless explored in subanal-
ses. Studies were excluded where there was no assessment of
europsychological function, the assessment did not include any
easures included in the consensus statement, or means and stan-
ard deviations were not reported in the paper. Studies were
xcluded if they did not report preoperative performance.
.3. Overview of consensus statement neuropsychological tests
Grooved  Pegboard: this assesses ﬁne motor speed as the individ-
al simply has to place pegs in holes as quickly as possible. Digit
ymbol Test: requires the individual to draw the correct symbols
o match numbers as quickly as possible according to a ‘key’ that is
eft in front of them – assesses psychomotor speed. Trails A/B Test: is
lso a test of psychomotor speed that additionally requires a greater
egree of planning and working memory (executive functions). It
equires the individual to draw lines to connect letters and numbers
n a pre-speciﬁed sequence. RAVLT – Rey Auditory Verbal Learning
est: assesses short-term memory for supraspan word lists.
.4.  Statistical analysis
The  outcomes were analyzed as continuous variables based on
he mean and standard deviation. The weighted mean difference
as calculated for each outcome. The meta-analysis was  performed
sing Review Manager (RevMan) Version 5 for Windows. (Copen-
agen: The Nordic Cochrane Centre, The Cochrane Collaboration,
008). Further analysis was carried out using PASW18 (SPSS).
eterogeneity across trials was quantiﬁed using the I2 statistic.
andom effects (Der-Simonian and Laird) model was chosen for
ll analyses, as a large number of comparisons showed signiﬁcant
eterogeneity. Statistical signiﬁcance was deﬁned as two-sided
 < 0.05.
. Results
Initial search yielded 435 papers, of which 220 were selected for
reliminary review as potentially meeting the criteria. From these,
8 met  the inclusion criteria and were included in the ﬁnal analysis
see Table 1 for overview). The main reasons for study exclusion
ere lack of consensus statement neuropsychological tests (23.6%), Ta
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Table 3
Summary of Digit Symbol meta-analysis results.
Study CPB Baseline Very early Early Late
Mean SD  n Mean SD n ES 95% CI Mean SD n ES 95% CI Mean SD n ES 95% CI
Dupuis et al. (2006) On 39.00 11.90 364 41.60 11.80 546 0.22 [0.09,  0.35]
Ernest  et al. (2006) On  45.93 12.82 46 48.71 14.10 31 0.21 [−0.25, 0.66] 49.94 12.46 32 0.31 [−0.14, 0.77]
Off  49.03 12.28 61 51.58 13.43 44 0.20 [−0.19, 0.59] 52.30 13.96 32 0.25 [−0.18, 0.68]
Grigore  et al. (2002) On 39.55  12.87 100 43.06 13.90 100 0.26 [−0.02, 0.54]
Khosravi et al. (2005) On 38.09 9.50 20 41.39 11.50 20 0.31 [−0.32, 0.93] 40.49 11.90 20 0.22 [−0.40, 0.84]
Lee  et al. (2003) On 52.50  17.00 29 35.50 19.50 29 −0.92 [−1.46, −0.37] 53.80 22.10 30 0.06 [−0.45, 0.58]
Off  45.30 17.00 29 42.90 12.00 29 −0.16 [−0.68, 0.35] 43.70 14.50 30 −0.10 [−0.61, 0.41]
Lund  et al. (2005) On  36.40 9.60 60 38.80 9.70 52 0.25 [−0.13, 0.62] 39.10 10.10 52 0.27 [−0.10, 0.65]
Off 36.60 8.90 60 38.90 10.40 54 0.24 [−0.13, 0.61] 38.50 10.20 52 0.20 [−0.17, 0.57]
Newman  et al. (2001) On 38.78 13.71 261 33.44 13.60 252 −0.39 [−0.57, −0.22] 45.28 14.24 222 0.47 [0.28, 0.65] 46.46 14.02 210 0.55 [0.37, 0.74]
Robson  et al. (2000) On 42.60 9.00 102 44.10 10.50 102 0.15 [−0.12, 0.43]
Silbert et al. (2004) On 33.80  13.80 50 27.70 12.50 50 −0.46 [−0.86, −0.06] 38.20 10.70 280 0.40 [0.23, 0.57] 38.50 11.20 280 0.42 [0.25, 0.59]
Sugiyama  et al. (2002) On 39.00 11.00 65 39.00 13.00 65 0.00 [−0.34, 0.34]
Szalma et al. (2006) On 27.56 11.94 46 29.57 11.10 47 0.17 [−0.23, 0.58]
Van Dijk et al. (2002) On 39.00 7.96 139 42.00 7.10 120 0.39 [0.15, 0.64] 41.00 8.28 122 0.25 [0.00, 0.49]
Off 41.00  8.90 142 45.00 9.00 128 0.45 [0.20, 0.69] 42.00 9.40 122 0.11 [−0.13, 0.35]
Vedin  et al. (2006) On 36.00 10.64 37 41.00 4.37 34 0.60 [0.12, 1.08] 39.00 7.07 32 0.32 [−0.15, 0.80]
Off  40.00 10.05 33 42.00 6.95 31 0.23 [−0.26, 0.72] 42.00 4.10 32 0.26 [−0.23, 0.74]
Wang  et al. (2002) On 30.00 10.00 45 27.60 11.10 45 −0.23 [−0.64, 0.19]
Zamvar et al. (2002) On 42.80 18.19 30 35.46 9.60 29  −0.50 [−1.01, 0.02] 38.74 8.10 30 −0.28 [−0.79, 0.22]
Off 42.47 10.23 30 40.97 8.10 30 −0.16 [−0.67, 0.35] 45.30 6.70 30 0.32 [−0.19, 0.83]
Total N  = 514, 504 −0.30* [−0.5, 0.09] N = 1472, 1350 0.29** [0.20, 0.39] N = 1561, 1592 0.29** [0.20, 0.38]
CPB – cardio pulmonary bypass status; ES – effect size estimate (standardized mean difference).
* Signiﬁcant p < 0.05.
** Signiﬁcant p < 0.001.
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no report of means and standard deviations (27.9%), patient groups
that did not meet inclusion criteria (e.g. mix  of ﬁrst time and re-
do operations, or concomitant valve surgery: 6.4%). The details of
the studies included in the meta-analysis, including demographics
and study design are presented in Table 1; funnel plots showed no
publication bias. The results of the meta-analysis are summarized
in Tables 2–6.
At  the earliest post-operative time point (<2 weeks post-
surgery: ‘very early’) data were available from 1003 participants
in total, across all studies and sub-groups. A statistically sig-
niﬁcant slowing in the Digit Symbol (Z = −2.82; p = 0.005) and
Grooved Pegboard tests (Z = −2.33, p = 0.02) was  observed. How-
ever the other measures showed no signiﬁcant difference from
baseline (RAVLT: Z = −0.76, p = 0.45; Trails A: Z = 1.37, p = 0.17/Trails
B: Z = 0.01, p = 1.00). Thus, at this earliest time point post-surgery
(often pre-discharge from hospital), two measures indicated that
speed of psychomotor performance was reduced but higher forms
of cognitive function (memory, executive function) remained sta-
ble.
Three months post-operative (‘Early’) follow-up data were
available from a total of 1933 participants. At this time a signiﬁ-
cant improvement is seen all measures (RAVLT: Z = 4.22 p < 0.001;
Trails A: Z = 4.91, p < 0.001/Trails B: Z = 3.15, p = 0.002; Digit Symbol
test: Z = 5.98, p < 0.001); Grooved Pegboard test: Z = 1.99, p = 0.05).
This shows that by three months post-CABG, psychomotor speed
had normalized and that in fact all measures showed improvement
relative to baseline.
At  the late (6–12 months: ‘Late’) time point, data were available
from 2043 participants and once again signiﬁcant improvements
were seen in the majority of measures (RAVLT: Z = 6.69, p < 0.001;
Trails A: Z = 4.80, p < 0.001; Digit Symbol test: Z = 6.30, p < 0.001;
Grooved Pegboard test: Z = 4.53, p < 0.001). Trails B was  not signiﬁ-
cantly different to baseline (Z = 1.81, p = 0.07). However, when data
from one study with very long completion times both pre and post
operatively were excluded (Kadoi and Goto, 2006), this comparison
became signiﬁcant (Z = 4.74, p < 0.001), and the heterogeneity was
reduced to non-signiﬁcant levels (I2 82% vs. 44%).
In summary, across all four measures there was  a trend towards
improvement in cognitive function following CABG surgery, not
decline. This is demonstrated in Fig. 1.
3.1. Cardio-pulmonary bypass
A number of the studies reported the comparison of on- and off-
pump CABG. The effect of bypass on cognition was not the focus
of the present meta-analysis and our selection criteria were not
designed to compare these different interventions in a systematic
way. However, our ﬁndings are broadly consistent with those of
another recent meta-analysis (Marasco et al., 2008) in demonstrat-
ing only very limited differences between on and off pump groups.
On-pump CABG patients were slower on the Digit Symbol sub-
test at the earliest time point (<2 weeks; X2 = 7.1, df = 2, p = 0.03).
Conversely, the on-pump group performed better at late follow up
(6–12 months; X2 = 3.74, df = 1, p = 0.05).
3.2. Meta-regression
Random-effects inverse variance weighted regression was car-
ried out to investigate the impact of age, gender balance, incidence
of hypertension, diabetes and drop-out rate on post-operative
outcome at each time point. Study data were collapsed across
sub-group and outcome measure at each time point, yielding one
index of effect size per study for each time point. The predic-
tors were entered separately and together. The only signiﬁcant
predictor was  drop-out rate at time 1 (‘very early’ assessment),
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Table 5
Summary of Trails A meta-analysis results.
Study CPB Baseline Very early Early Late
Mean SD n Mean SD n ES 95%  CI Mean SD n ES 95% CI Mean SD n ES 95% CI
Ahlgren et al. (2003) On 47.30 17.80 23 49.50 23.70 23 −0.10 [−0.68, 0.48]
Baker  et al. (2001) On 41.71 13.30 14 40.71 19.40 14 0.06  [−0.68, 0.80] 40.90 11.41 10 0.06 [−0.75, 0.87]
Off 38.83  13.55 12 31.75 8.96 12 0.60 [−0.23, 1.42] 30.75 6.50 8 0.68 [−0.24, 1.61]
Ernest  et al. (2006) On 41.13 14.82 46 39.00 17.58 41 0.13 [−0.29,  0.55] 41.69 15.42  32 −0.04 [−0.49, 0.41]
Off 42.64 14.96 61 39.39 11.49 44 0.24 [−0.15, 0.63] 37.45 11.33 47 0.38 [0.00, 0.77]
Heyer  et al. (2002) On 39.39 17.28 35 44.66 24.15 34 −0.25 [−0.72, 0.23] 40.60 15.52 29 −0.07  [−0.56, 0.42]
Lee  et al. (2003) On 43.70 32.60 26 42.80 33.10 26 0.03 [−0.52, 0.57] 43.40 34.40 26 0.01 [−0.53, 0.55]
Off 47.40  22.20 27 41.60 16.50 27 0.29 [−0.24, 0.83] 45.70 15.20 27 0.09 [−0.45, 0.62]
Kadoi  and Goto (2006) On 46.90  5.10 88 45.90 5.90 88 0.18 [−0.12, 0.48]
Knipp  et al. (2004) On 46.40 12.70 35 44.90 15.10 29 0.11 [−0.39, 0.60]
Müllges  et al. (2002) On 22.50 7.30 52 18.90 7.10 52 0.50 [0.11, 0.89]
Rankin  et al. (2003) Both 40.75 19.83 41 38.85 19.69 34 0.10 [−0.36, 0.55]
Robson  et al. (2000) On 33.30 11.40 102 33.10 10.90 102 0.02 [−0.26, 0.29]
Rubens  et al. (2007) On 34.78 13.35 125 35.70 10.63 118 −0.08 [−0.33, 0.18] 31.98 10.42 113 0.23 [−0.02, 0.49]
Selnes  et al. (2009) On 47.10 24.20 151 40.80 16.80 123 0.30 [0.06, 0.54]
Off 48.00  23.00 69 43.40 17.50 55  0.22 [−0.14, 0.58]
Silbert  et al. (2004) On 52.00 23.00 50 60.90 38.70 50 −0.28 [−0.67, 0.12] 49.60 20.00 282 0.24 [0.08, 0.41] 48.60 20.00 282 0.29 [0.12, 0.45]
Stygall  et al. (2003) On 40.34 13.32 107 36.83 11.19 107 0.28 [0.01, 0.55] 33.98 9.96 107 0.54 [0.27, 0.81] 38.78 14.14 107 0.11 [−0.16, 0.38]
Vedin  et al. (2006) On 37.00 16.72 37 32.00 7.28 34 0.38 [−0.09, 0.85] 34.00 7.07 32 0.23 [−0.25, 0.70]
Off 34.00 11.48 33 29.00 5.56 31 0.54 [0.04, 1.04] 32.00 8.21 30 0.20 [−0.30, 0.69]
Zamvar  et al. (2002) On 40.37 14.22 30 26.82 15.50 29 0.90 [0.36, 1.44] 38.74 13.00 30 0.12 [−0.39, 0.62]
Off 43.57 15.41 30 37.37 17.80 30 0.37 [−0.14, 0.88] 40.57 8.60 30 0.24 [−0.27, 0.75]
Zimpfer  et al. (2004) On 34.70  9.10 104 36.80 9.20 104 −0.23 [−0.50, 0.04]
Total  N = 612, 603 0.14 [−0.06, 0.34] N = 987, 929 0.23** [0.14, 0.32] N = 953, 867 0.23** [0.13, 0.32]
CPB – cardio pulmonary bypass status; ES – effect size estimate (standardized mean difference).
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Table 6
Summary of Trails B meta-analysis results.
Study CPB Baseline Very early Early Late
Mean SD n Mean SD n ES 95% CI Mean SD n ES 95% CI Mean SD n ES 95% CI
Ahlgren et al. (2003) On 129.20 56.70 23 125.80 60.10 23 0.06 [−0.52, 0.64]
Baker et al. (2001) On 115.50 44.98 14 123.64 66.76 14 −0.14 [−0.88, 0.60] 107.30 70.58 10 0.14 [−0.67, 0.95]
Off  86.17 24.79 12 85.25 24.68 12 0.04 [−0.76, 0.84] 84.75 24.04 8 0.06 [−0.84, 0.95]
Ernest  et al. (2006) On 111.64 45.01 46 100.97 33.22 31 0.26 [−0.20, 0.72] 102.77 38.00 32 0.21 [−0.24, 0.66]
Off  144.22 56.87 61 97.26 41.78 44 0.91 [0.50, 1.32] 100.24 45.42 47 0.84 [0.44, 1.23]
Grigore  et al. (2002) On 184.98 226.30 100 160.42 159.72 100 0.12 [−0.15, 0.40]
Heyer et al. (2002) On 88.19 41.50 35 103.43 49.14 34 −0.33 [−0.81, 0.14] 85.90 36.10 29 0.06 [−0.43, 0.55]
Kadoi and Goto (2006) On 167.90 29.70 88 198.80 35.80 88 −0.94 [−1.25, −0.62]
Knipp  et al. (2004) On 114.60 36.80 35 104.90 33.80 29 0.27 [−0.22, 0.76]
Lee et al. (2003) On 114.90 87.60 29 117.20 104.50 29 −0.02 [−0.54, 0.49] 104.40 92.10 26 0.12 [−0.41, 0.65]
Off 126.00  86.70 29 115.60 52.30 29 0.14 [−0.37, 0.66] 117.30 63.40 27 0.11 [−0.41, 0.64]
Müllges  et al. (2002) On  52.40 22.00 52 46.80 19.30 52 0.27 [−0.12, 0.65]
Newman  et al. (2001) On  142.24 73.56 261 158.77 81.81 252 −0.21 [−0.39, −0.04] 109.93 62.64 222 0.47 [0.29, 0.65] 106.77 64.27 210 0.51 [0.32, 0.69]
Rankin  et al. (2003) Both 111.25 60.39 41 104.85 67.04 34 0.10 [−0.36, 0.55]
Robson et al. (2000) On 90.40 46.40 102 89.80 48.70 102 0.01 [−0.26, 0.29]
Rubens et al. (2007) On  82.60 45.57 125 93.87 31.28 118 −0.29 [−0.54, −0.03] 76.95 24.66 113 0.15 [−0.10, 0.41]
Selnes et al. (2009) On 105.20 59.00 147 95.40 48.20 122 0.18 [−0.06, 0.42]
Off  96.90 34.70 68 97.20 48.40 55 −0.01 [−0.36, 0.35]
Silbert  et al. (2004) On 125.40 74.50 50 158.50 138.60 50 −0.30 [−0.69, 0.10] 113.20 59.30 281 0.21 [0.04, 0.37] 110.70 58.70 281 0.25 [0.09, 0.42]
Stroobant  et al. (2008) Both 123.70 77.50 50 127.40 58.00 49 −0.05 [−0.45, 0.34] 108.00 55.50 40 0.23 [−0.19, 0.64]
Stygall  et al. (2003) On 87.67 36.59 107 76.31 31.80 107 0.33 [0.06, 0.60]
Van Dijk et al. (2002) On 94.00 39.78 139 79.00 33.93 120 0.40 [0.16, 0.65] 76.00 32.76 122 0.49 [0.24, 0.74]
Off 83.00  40.56 142 75.00 33.93 128 0.21 [−0.03, 0.45] 77.00 35.88 130 0.16 [−0.08, 0.39]
Vedin  et al. (2006) On 104.00 54.74 37 81.00 14.57 37 0.57 [0.10, 1.03] 83.00 11.31 37 0.53 [0.06, 0.99]
Off  82.00 28.72 33 88.00 16.70 33 −0.25 [−0.74, 0.23] 84.00 9.58 33 −0.09 [−0.58, 0.39]
Zamvar  et al. (2002) On 94.93 34.99 30 61.52 34.40 29 0.95 [0.41, 1.49] 122.17 31.00 30 −0.81 [−1.34, −0.29]
Off 98.30 36.09 30 80.34 53.10 30 0.39 [−0.12, 0.90] 98.56 19.90 30 −0.01 [−0.51, 0.50]
Total N = 717, 698 0.00 [−0.19, 0.19] N = 1628, 1493 0.20* [0.08, 0.33] N = 1437, 1268 0.18 [−0.01, 0.38]
CPB – cardio pulmonary bypass status; ES – effect size estimate (standardized mean difference).
* Signiﬁcant p < 0.05.
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Table  7
Summary of meta-regression analyses.
Time point Predictor N Nps Mean ES  ˇ 95% CI B SE R2 Z p
Very early
Age 12 743 −0.067 0.112 [−0.051, 0.073] 0.011 0.032 0.012 0.35 0.73
Gender (% m) 12 743 −0.072 −0.417 [−0.063, 0.009] −0.027 0.018 0.174 −1.45 0.15
Hypertension 9 556 −0.135 0.19 [−0.007, 0.012] 0.003 0.005 0.036 0.55 0.61
Drop-out 13 1004 −0.114 −0.513 [−0.118, −0.001] −0.06 0.03 0.263 −1.99 0.046*
Diabetes 9 556 −0.137 −0.323 [−0.054, 0.02] −0.017 0.019 0.104 −0.89 0.37
Early
Age  17 1672 0.211 0.335 [−0.008, 0.032] 0.012 0.01 0.112 1.19 0.23
Gender (% m) 17 1672 0.211  −0.534 [−0.019, 0] −0.009 0.005 0.285 −1.89 0.06
Hypertension 12 1316 0.219 0.078 [−0.005, 0.007] 0.001 0.003 0.006 0.24 0.81
Drop-out 18 1933 0.24 0.239 [−0.003, 0.008] 0.003 0.003 0.057 0.97 0.33
Diabetes 11 1196 0.208 −0.19 [−0.015, 0.008] −0.003 0.006 0.036 −0.55 0.58
Late
Age  12 1418 0.196 0.314 [−0.023, 0.069] 0.023 0.024 0.098 0.986 0.32
Gender (% m) 13 1782 0.2 −0.175 [−0.018, 0.01] −0.004 0.007 0.031 −0.569 0.57
Hypertension 10 1291 0.205 0.09 [−0.01, 0.013] 0.001 0.006 0.008 0.232 0.82
Drop-out 14 2043 0.235 0.227 [−0.003, 0.007] 0.002 0.003 0.051 0.746 0.46
Diabetes 10 1535 0.191 0.116 [−0.02, 0.028] 0.004 0.012 0.013 0.336 0.74
N  mean
w
(
4
d
i
f
n
F
ﬁ
a = number of studies in the meta-regression; Nps – number of patients; mean ES –
* Signiﬁcant p < 0.05.
here a higher drop-out rate was associated with worse outcome
 ˇ = −.513, p = .0457) (Table 7).
. Discussion
This meta-analysis shows evidence for very early post-operative
ecline in two of the four main consensus statement tests, specif-
cally in two measures that are sensitive to speeded psychomotor
unction. These deﬁcits were reversed by three months with sig-
iﬁcant improvement relative to baseline in all four measures.
ig. 1. Forest Plot across all time points and studies, showing effect size and 95% Con-
dence Interval for each comparison (separate lines for each measure and subgroup)
t each follow up time. Size of markers indicates study weighting. effect size (standardized mean difference).
Improvement was  sustained at the latest assessment time, up to
one year post-CABG surgery. It is important to bear in mind that
these ﬁndings are based on group level statistics, and may thus
obscure individual patients’ trajectories of postoperative cognitive
change. Nevertheless, a tendency towards preservation of pre-
operative function (even improvement), rather cognitive decline,
is seen in the ﬁrst year following CABG surgery, supporting ear-
lier case-series (McKhann et al., 2005; Selnes et al., 2003; Van den
Goor et al., 2008) which show that post-operative cognitive decline
in the ﬁrst year after CABG surgery is not inevitable.
There are a number of issues which must be considered when
interpreting these data. Firstly, repeated neuropsychological test-
ing would be expected to result in improvement due to practice
effects (Selnes et al., 2009). However, this confound is mitigated by
the use of parallel test versions (Van den Goor et al., 2008), so that,
for example, different word lists are used pre and post operatively.
Importantly, parallel forms are a key feature of the consensus state-
ment tests, the use of which was  a main inclusion criterion of this
meta-analysis. If this recommendation was diligently implemented
in the studies reported, it would serve to substantially reduce this
confound. Practice effects are strongest over short test–retest inter-
vals, making it difﬁcult to reconcile this interpretation with the
temporal pattern of short term decline in two  of the measures
followed by the improvement months later which we observed.
Test performance would also be expected to improve with addi-
tional repetitions of the same test, but our effect size estimates
at the late time point were similar irrespective of whether it was
the ﬁrst, second or third post-operative assessment the patients
had received (F = 0.93; p = 0.39). Finally, the ability to beneﬁt from
practice is likely to be positively related to the level of baseline
cognitive functioning (Wilson et al., 2002), suggesting that not all
of the patients would have beneﬁtted from practice effects equally.
Thus, although we acknowledge that this is a potential confound
in repeated neuropsychological assessment, we  do not feel it can
adequately explain the pattern of results observed. A further possi-
bility is that patient drop-out from longitudinal assessment leads to
a  bias in outcome data, with only the most well patients willing and
able to participate. This could artiﬁcially elevate scores on tests of
cognitive function. However, the converse could also be true, in that
the least well patients may  commit to longitudinal studies as they
are motivated by concern that something is wrong. Whilst not a
deﬁnitive answer to this potential confound, our meta-regression
indicates that higher ‘very early’ drop-out rate is associated with
less favourable outcome at this time point, which is not consistent
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ith selective drop out spuriously elevating scores. Nevertheless,
uture studies should provide further detail of the neuropsychologi-
al proﬁle of those patients who drop-out of follow-up compared to
hose who remain in longitudinal studies. In summary, we consider
hat improvement in performance during the ﬁrst post-operative
ear is unlikely to be solely due to practice effects, nor to be overly
nﬂuenced by patient drop-out rates.
There is a great deal of variability in cognitive function in these
atients prior to CABG surgery. This consists not only of between-
ubjects variability at a single time point, but also of ﬂuctuation
nd decline within individuals across time. As many as 46% of
atients show signiﬁcant impairments in cognitive function pre-
peratively, compared to 29% of controls (Rosengart et al., 2005).
hese deﬁcits have been associated with comorbidities such as dia-
etes and hypertension, and also with stroke which may  affect up
o 6% of patients before surgery (Glance et al., 2007; Tarakji et al.,
011). In our current analysis, the rate was between 2.7% and 7.1%,
onsistent with these earlier reports. We  were unable to include
re-operative stroke rate in our meta-regression, but neither dia-
etes nor hypertension were signiﬁcant predictors of cognitive
utcome. Vascular disease in general is associated with both subtle
ognitive decline and increased risk of dementia (Desmond, 2004;
nopman et al., 2001; Popovic et al., 2011; Selnes et al., 2009).
ndeed, in CABG surgery patients, asymptomatic carotid artery
tenosis independently accounts for 50% of the variance in post-
perative cognitive decline (Norkiené et al., 2011). Thus, cognition
s not stable in an ageing population with underlying cardiovas-
ular disease, and test performance can be expected to decline
ver the course of a year (McKhann et al., 2005; Okonkwo et al.,
010; Wilson et al., 2002) even without surgery. Studies of CABG-
urgery patients that have utilized appropriate control groups, such
s non-surgical patients with cardiovascular disease, support this
onclusion (McKhann et al., 2005; Selnes et al., 2003; Van Dijk
t al., 2008). Taken together, this suggests that cognitive outcome
hould be considered against the rate of change in an age matched
ontrol group with similar cardiovascular risk factors (Abildstrom
t al., 2000; McKhann et al., 2005; Mutch et al., 2011; Selnes et al.,
012), rather than simply relative to baseline. Such an approach
ould also enable the elimination of artefacts related to practice
ffects.
In addition to the global increase in cognitive scores reported
n this meta-analysis, an early transient decline was found in two
easures of speeded psychomotor function (Grooved Pegboard
nd Digit Symbol). Although ‘Trials A’ also requires psychomotor
peed (Sanchez-Cubillo et al., 2009) we did not ﬁnd a decline in
his test. However, this test requires a greater working memory
nd motor planning contribution than the other two  tests, perhaps
aking it a less speciﬁc measure of psychomotor speed. Slow-
ng of psychomotor speed, assessed both behaviourally and using
vent related potentials (Fowler and Lindeis, 1992; Havashi et al.,
005), has been consistently observed in conditions of hypoxia.
his leads us to speculate that brain vulnerability to transient
ypoxia might help to explain certain ﬁndings in this population,
uch as the association of early post-operative cognitive decline
ith intra-operative mean arterial pressure (Gottesman et al.,
007), cerebral oximetry (Slater et al., 2009), and the short-term
ecline in speeded psychomotor function demonstrated herein.
owever, simple measures to improve intra-operative brain oxy-
enation have not been found to improve early cognitive outcome
Slater et al., 2009). This may  be due to pre-operative expo-
ure of the CABG-surgery patient to chronic-intermittent hypoxia
wing to respiratory disease, smoking or sleep apnoea. Animal
odels suggest that chronic-intermittent hypoxia may result in
p-regulation of protective factors (e.g. hypoxia inducible factor)
hereby paradoxically offering protection to the brain (Chavez
nd LaManna, 2002). Another possible mechanism for cognitivevioral Reviews 36 (2012) 2118–2129 2127
decline  is systemic inﬂammation induced by surgery, although
there are few data to support this (Kálmán et al., 2006; Newman
et al., 2006). It should also be borne in mind that at the ear-
liest post-operative period, patients are receiving medication to
control pain which may  also have an impact on cognitive perfor-
mance. In summary, whilst this meta-analysis may  challenge the
prevailing assumption that most patients are affected negatively
by surgery, in order to address the issue more deﬁnitively, we
may need to update the methods of assessing cognitive function
by considering what is known regarding the pathophysiological
events following and preceding CABG surgery.
The majority of the studies included in this analysis com-
pared groups of patients undergoing CABG surgery with or without
cardio-pulmonary bypass. Cerebral vasculature may be obstructed
by emboli released into the circulation during cardio-pulmonary
bypass-associated manipulation of the aorta (Brown et al., 2009),
resulting in microvascular pathology, particularly in deep white
matter (Moody et al., 1990). Such pathology may  increase the risk
of future cognitive decline in the elderly (Jokinen et al., 2011; Prins
et al., 2005). However, a linear relationship between the number of
emboli recorded from the middle cerebral artery intra-operatively
and post operative decline has not been established (Van Dijk and
Kalkman, 2009), and both our data and that from other studies
reveal few consistent differences in outcome between on and off
pump CABG (Alston, 2011; Marasco et al., 2008; Selnes et al., 2012),
despite the lower burden of micro-emboli in the latter. This could
be due to the complex interdependent relationship between emboli
release during surgery, artherosclerosis, ageing (Boivie et al., 2010)
and the severity of vascular disease, all factors which can indepen-
dently impact cognitive function.
There are several potential explanations for the improved cog-
nitive function observed. Most straightforwardly patients simply
feel healthier (less angina) and thus are more motivated following
CABG surgery, enabling them to perform better on neuropsychol-
ogical tests. Cognition and quality of life could well be linked in
patients following CABG surgery (Bute et al., 2006). Whilst the pres-
ence of depression at six months post-operatively (Goyal et al.,
2005) suggests that improved mood may  be an unlikely explanation
for cognitive improvement in the present study there is also evi-
dence for return to baseline mental health by one year post-surgery
(Mathisen et al., 2010; Rothenhäusler et al., 2005), suggesting that
emotional status might improve alongside cognitive function, just
at a slower pace. Physiologically, a further potential mechanism
for improvement is better cardiac output following CABG surgery
in the immediate post-operative period. Indeed, impaired cardiac
output has been highlighted in the Framingham cohort as a poten-
tial cause of abnormal ageing of the brain (Jefferson, 2010; Jefferson
et al., 2011) suggesting the opposite, namely that its improvement
might offer some beneﬁt. Nevertheless, an important caveat when
considering the improvements in cognitive function observed over
the course of a year is that these do not preclude later cognitive
decline in subsequent years. There are currently few data and little
consensus regarding the long-term consequences of CABG (Mutch
et al., 2011; Selnes et al., 2009, 2012; Van Dijk et al., 2007). More
work is needed to evaluate the long-term impact of cardiovascular
disease and CABG surgery on cognitive function.
For a few patients, CABG surgery may  provide the catalyst for
cognitive deﬁcit that was  not present pre-operatively. In others,
it may  be an added burden on a neurocognitive system that is
already showing decline. In these cases it is of utmost impor-
tance to explore potentially modiﬁable peri-operative risk factors
that may  be associated with further brain insult (Selnes et al.,
2012). For example EEG, transcranial Doppler sonography (embo-
lus detection) and cerebral oximetry indicate acute deﬁcits in brain
perfusion and oxygenation during surgery; in fact the simple pres-
ence of such neuromonitoring can reduce the incidence of brain
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njury by half (6.1% vs. 3% in non-monitored compared to neu-
omonitored patients) (Edmonds, 2005). In the majority of patients,
owever, CABG surgery may  have a transient positive impact on a
rajectory of cognitive change that is already set in motion with
he ageing process and perhaps inﬂuenced by underlying vascular
isease. In a few fortunate patients, we cannot discount the possi-
ility that it may  boost neurocognitive function more permanently.
enetic studies have already identiﬁed candidate markers of brain
ulnerability to CABG surgery (Newman et al., 2006), and we
ave mooted the possibility that mechanisms underlying cognitive
hange reﬂect also expression of, for example, hypoxia protective
enes. Thus research into those patients who make a good recovery
ight paradoxically explain why other patients develop cognitive
ecline. The only way to fully address these hypotheses is through
ongitudinal studies that include controls with non-surgical treat-
ent of coronary artery disease, and bring to bear the cognitive
euroscience techniques which have developed since the consen-
us statement was initially formulated.
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